Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States

Evaluating hepatitis delta virus disease prevalence and patient characteristics among adults in the United States: An analysis of an all-payer claims database

by | Aug 19, 2022 | Hepatology Posters, Infectious Disease Posters, Presentations

Abstract Background and aims Hepatitis delta virus (HDV) infection leads to the most severe form of viral hepatitis and is always associated with hepatitis B virus (HBV) infection. This study estimates the prevalence and describes patient characteristics for...
Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States

Increased comorbidity burden among HDV infection vs HBV mono-infection among commercially insured adults in the United States: An All-Payer Claims Database analysis

by | May 25, 2022 | Hepatology Posters, Infectious Disease Posters, Presentations

Abstract BACKGROUND: Hepatitis delta is caused by a defective RNA virus (HDV) that requires the presence of hepatitis B surface antigen for replication and transmission. Compared to hepatitis B virus (HBV) monoinfection, patients with HDV have a greater risk of...
Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States

Hepatitis delta among commercially-insured patients in the United States: An analysis of prevalence, patient characteristics and socioeconomic status

by | May 25, 2022 | Hepatology Posters, Infectious Disease Posters, Presentations

Abstract BACKGROUND: Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) for its replication. HDV infection leads to the most severe form of viral hepatitis, which is associated with an increased risk of liver-related morbidity and mortality. HDV prevalence...